Skip to main content
Shanghai Pharmaceuticals Holding Co., Ltd. logo

Shanghai Pharmaceuticals Holding Co., Ltd. — Investor Relations & Filings

Ticker · 2607 ISIN · CNE1000012B3 HKEX Manufacturing
Filings indexed 1,462 across all filing types
Latest filing 2026-05-07 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2607

About Shanghai Pharmaceuticals Holding Co., Ltd.

http://www.sphchina.com

Shanghai Pharmaceuticals Holding Co., Ltd. is an integrated pharmaceutical enterprise operating across the entire healthcare value chain. Its core business activities include pharmaceutical research and development, manufacturing, distribution, and retail services. The company produces and markets a diverse portfolio of products, including innovative drugs, chemical drugs, traditional Chinese medicines (TCMs), and treatments for rare diseases. Shanghai Pharma maintains a leading position in both pharmaceutical manufacturing and distribution within the domestic market, serving as a major provider of comprehensive healthcare services.

Recent filings

Filing Released Lang Actions
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2026-05-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
Regulatory Filings
2026-05-06 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 92% confidence The document is extremely brief (under 5,000 characters) and only informs readers that an announcement has been published by the issuer elsewhere. It does not contain substantive report content or data, but merely notifies of publication. This matches the definition of a Report Publication Announcement (RPA).
2026-04-28 English
Notice of Publication of Corporate Communications and Invitation to Provide Email Address
Report Publication Announcement Classification · 85% confidence The document is a shareholder notification letter rather than the report itself. It announces the availability of the 2025/26 Annual Report on the company and HKEX websites and invites shareholders to provide an email address for future electronic notifications of corporate communications. There is no substantive financial data or report content; it simply notifies publication and provides a form. This matches a Report Publication Announcement (RPA).
2026-04-28 English
2025 Sustainability Report & Environmental, Social and Governance Report
Regulatory Filings
2026-04-28 English
2025 ANNUAL REPORT
Regulatory Filings
2026-04-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.